The largest database of trusted experimental protocols

Epics xl mcl

Manufactured by Beckman Coulter
Sourced in United States, Germany, Netherlands, France

The Epics XL-MCL is a flow cytometer system designed for advanced cellular analysis. It provides precise measurement and analysis of various cellular parameters, including size, granularity, and fluorescence intensity. The Epics XL-MCL is a versatile instrument suitable for a wide range of applications in the fields of immunology, cell biology, and hematology.

Automatically generated - may contain errors

190 protocols using epics xl mcl

1

Programmed Cell Death Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Programmed cell death (PCD) detection was performed in single GFP-positive cells. Early (phosphatidylserine exposure) and late (membrane permeabilization) PCD stages were studied by Annexin V-PE Apoptosis Detection Kit I (BD Pharmingen) and flow cytometry (EPICs XL-MCL, Beckman Coulter). DNA fragmentation was studied in the end-stage PCD by TUNEL- (terminal deoxynucleotidyl transferase dUTP nick end labeling-) based APO-BRDU Kit (BD Pharmingen) and flow cytometry (LSRII, BD Biosciences). To avoid the overlap with GFP-marker, FITC-labeled anti-BRDU mAb was substituted with the PE-conjugated anti-BRDU mAb (BD Pharmingen). Results were analyzed as the mean ± SE, and compared using an independent two-sample t-test at P < 0.05 level of significance. Cell cycle analysis was performed in parental and transfected (vector-, WT/DN-ANXA7-, or p53-) LNCaP cells (18 h), using propidium iodide staining (Sigma-Aldrich) and flow cytometry (ModFit LT, Verity Software House and EPICs XL-MCL, Beckman Coulter).
+ Open protocol
+ Expand
2

Apoptosis and Cell Cycle Analysis of MWCNT-treated A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells were collected after MWCNT treatment, and washed twice with PBS. For apoptosis detection, the cells were suspended in 400 µl binding buffer and incubated with 5 µl Annexin V-FITC (MultiSciences, Hangzhou, China) and 5 µl PI in the dark at 37°C for 15 min. Cells were put on ice until analysis. The ratio of apoptotic cells was measured using a Beckman Coulter Epics XL-MCL device (Fullerton, CA, USA).
For cell cycle detection, cells were fixed in 70% ethanol for at least 2 h. After fixation, cells were centrifuged at 200 g for 5 min, and the cell pellet suspended in 500 µl propidium iodide (PI)/Triton X-100 staining solution containing RNase A for 15 min at 37°C. Cell cycle was assessed using a Beckman Coulter Epics XL-MCL device.
+ Open protocol
+ Expand
3

Comprehensive Cell Death Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity and viability were determined by LDH Cytotoxicity Detection
Kit and XTT Cell Proliferation Kit II, respectively (both from Roche Applied
Science, Indianapolis, IN). PCD was detected by Annexin V-PE and APO-BRDU
Apoptosis Detection Kits (both from BD Pharmingen, San Jose, CA) using only
single green fluorescence protein (GFP)-positive cells. Early
(phosphatidylserine exposure) and late (membrane permeabilization) stages of PCD
were analyzed by flow cytometry (EPICs XL-MCL, Beckman Coulter, Fullerton, CA)
using Annexin V-PE assay. DNA fragmentation in the end-stage PCD was detected by
flow cytometry (LSRII, BD Biosciences, San Jose, CA) with the use of exogenous
terminal deoxynucleotidyl transferase (TdT), commonly defined as the TUNEL assay
[18 (link)]. We bought the reagent
APO-BrdU™ TUNEL Assay Kit, with Alexa Fluor™ 488 Anti-BrdU from
ThermoFisher. Cell cycle analysis was based on propidium iodide staining after
dsRNA removal by DNase-free RNase (Sigma-Aldrich, St. Louis, MO) in the cells
fixed in 70% ethanol. ModFit LT (Verity Software House, Topsham, ME) was used
for immediate flow cytometry analysis (EPICs XL-MCL, Beckman Coulter, Fullerton,
CA). Statistical analysis was performed on replicates using Student’s
t-test for independent samples or two-tailed Z-test for proportions; p-values
<0.05 (two-sided test) were considered statistically significant.
+ Open protocol
+ Expand
4

Cell Cycle and Apoptosis Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell cycle distribution and the apoptosis rate were analyzed using flow cytometry as previously described.28 (link) After incubating with different concentrations of LR042 (0, 5, and 10 μM), LR042 (0, 5, and 10 μM), and 125I for 72 h, the cells were trypsinized, washed with PBS, and fixed with 70% ethanol overnight at 4 °C. The fixed cells were washed with PBS and stained with propidium iodide (PI) for 15 min in the dark. Then, the cell cycle arrest was analyzed using an Epics XL-MCL flow cytometer (Beckman Coulter, Miami, FL, USA). The treated and untreated cells were trypsinized, washed with PBS, and costained with Annexin V and PI for 10 min, respectively. The apoptosis of cells was analyzed using an Epics XL-MCL flow cytometer (Beckman Coulter).
+ Open protocol
+ Expand
5

Annexin V Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated as indicated and incubated for 18 h at 37°C. Cells were collected, centrifuged at 200 × g for 5 min, supernatant discarded and the pellet was washed with 1× buffer. Cells were then resuspended in 90 μl of 1 × buffer and 10 μl of FITC-conjugated annexin V (Molecular Probes®, Grand Island, NY), incubated in the dark and analyzed using a Coulter® epics® XL-MCL.
+ Open protocol
+ Expand
6

Quantifying Neutrophil CD11b Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten µL HDL of a tenfold concentrated stock solution was added to 90 µL PMNL suspension (0.3 × 106 cells/mL) and incubated for 30 min at 37 °C. Then, 10 µL PBS or N-formyl-methionyl-leucyl-phenylalanine (fMLP; Sigma-Aldrich Chemie GmbH, Steinheim, Germany) stock solution (10−7 M) was added and incubated for another 30 min at 37 °C. After addition of a fluorescence labelled monoclonal antibody (PC5-anti-CD11b; Immunotech Beckman Coulter, Marseille, France) the samples were incubated for 45 min at room temperature and put on ice. 500 µL ice cold PBS was added. Flow cytometry was performed on an Epics XL-MCL (Coulter, Hialeah, FL, USA). The CD11b surface expression was measured as mean fluorescence intensity (MFI).
+ Open protocol
+ Expand
7

Measuring CD14 Expression on PMNLs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten microliters of HDL of a tenfold concentrated stock solution was added to 90 µL PMNL suspension (0.3 × 106 cells/mL). After incubation for 30 min at 37°, 10 µL PBS or fMLP (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) stock solution (10−7 M) was added and incubated for a further 30 min at 37 °C. The samples were incubated for 45 min at room temperature in the presence of a fluorescence-labelled monoclonal antibody (ECD-anti-CD14; Immunotech Beckman Coulter, Marseille, France) and then placed on ice. After addition of 500 µL ice cold PBS, flow cytometry was performed on an Epics XL-MCL (Coulter, Hialeah, FL, USA). The surface expression was measured as percentage of CD14 positive cells.
+ Open protocol
+ Expand
8

DNA Content Analysis of Malignant Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coulter DNA Prep Kit (Beckman Coulter) was used for quantitative measurements of DNA content in malignant tissues. Fluorescence-stained samples were analyzed by flow cytometry with a Coulter Epics XL-MCL flow cytometer and data were evaluated with MultiCycle AV Software (Phoenix Flow Systems). A minimum of 1×104 events were analyzed for each sample. DNA determinations provided information on the percentage of cells in the S phase of the cycle, which was subsequently used as a marker of cellular proliferation among malignant tissues.
+ Open protocol
+ Expand
9

Vitronectin-Mediated Complement Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze whether vitronectin bound to the microbial surface is functionally active, the microbial pathogens were incubated with vitronectin purified from human plasma (10–50 μg/ml) (Corning, Kaiserslautern, Germany) for 30 min at 37°C. After three washes, microbes were incubated with C5b-6 (1 μg/ml) and C7 (1 μg/ml) for 5 min, and thereafter C8 (0.4 μg/ml) and C9 (1 μg/ml) were added for 30 min at 37°C. All these complement factors were purchased from Complement Technology (Tyler, TE). After washing, deposited C5b-9 was detected by mouse anti-human C5b-9 mAb (Abcam, Cambridge, UK) followed by Alexa fluor-647-conjugated polyclonal goat anti-mouse pAb (Abcam). After two additional washes, microbes were analyzed by flow cytometry (EPICS XL-MCL; Coulter, Hialeah, FL). All incubations were kept in a final volume of 100 μl PBS-BSA and washings were done with the same buffer. Primary and secondary pAb were added separately as negative controls for each strain analyzed.
+ Open protocol
+ Expand
10

Characterization of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were characterized at the second passage. The cells
were incubated with antibodies against CD45 PC5, CD73
PE, CD105 FITC, and NG2 PE. A total of 20,000 cells/
sample at a flow rate of approximately 200 cell events/s were
recorded to obtain fluorescence histograms. A Coulter Epics
XL-MCL was used during the experiments and the data
were analyzed using EXPO 32 ADC software (Beckman
Coulter Inc., USA). Flow cytometry analysis revealed that
there were significant expressions of CD105, CD73, and
NG2, which are specific to MSC antigens, while there was
no detection of CD45, which is specific to the hematopoietic
marker antigen (Figure 2). These results showed that these
cells are MSCs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!